Abstract
GPCR ligands represent not only one of the major classes of current drugs but the major continuing source of novel potent pharmaceutical agents. Because 3D structures of GPCRs as determined by experimental techniques are still unavailable, ligand-based drug discovery methods remain the major computational molecular modeling approaches to the analysis of growing data sets of tested GPCR ligands. This paper presents an overview of modern Quantitative Structure Activity Relationship (QSAR) modeling. We discuss the critical issue of model validation and the strategy for applying the successfully validated QSAR models to virtual screening of available chemical databases. We present several examples of applications of validated QSAR modeling approaches to GPCR ligands. We conclude with the comments on exciting developments in the QSAR modeling of GPCR ligands that focus on the study of emerging data sets of compounds with dual or even multiple activities against two or more of GPCRs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Becker OM, Dhanoa DS, Marantz Y, Chen D, Shacham S, Cheruku S, Heifetz A, Mohanty P, Fichman M, Sharadendu A, Nudelman R, Kauffman M, Noiman S (2006) An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression. J Med Chem 49:3116–3135
Bissantz C, Bernard P, Hibert M, Rognan D (2003) Protein-based virtual screening of chemical databases. II. Are homology models of G-protein coupled receptors suitable targets? Proteins 50:5–25
Blower PE, Yang C, Fligner MA, Verducci JS, Yu L, Richman S, Weinstein JN (2002) Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data. Pharmacogenomics J 2:259–271
Bordas B, Komives T, Szanto Z, Lopata A (2000) Comparative three-dimensional quantitative structure-activity relationship study of safeners and herbicides. J Agric Food Chem 48:926–931
Charifson PS, Wyrick SD, Hoffman AJ, Simmons RM, Bowen JP, McDougald DL, Mailman RB (1988) Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands. J Med Chem 31:1941–1946
Charifson PS, Bowen JP, Wyrick SD, Hoffman AJ, Cory M, McPhail AT, Mailman R B (1989) Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands. J Med Chem 32:2050–2058
Chemical Diversity (2004) ChemDiv Chemical Database. www.chemdiv.com. Cited 28 November 2006
Cho SJ, Zheng W, Tropsha A (1998) Rational combinatorial library design. Rational design of targeted combinatorial peptide libraries using chemical similarity probe and the inverse QSAR approaches. J Chem Inf Comput Sci 38:259–268
Clark RD, Sprous DG, Leonard JM (2001) Validating models based on large dataset. In: Höltje H-D, Sippl W (eds) Rational approaches to drug design, Proceedings of the 13th European Symposium on Quantitative Structure-Activity Relationship, Aug 27–Sept 1. Prous Science, Düsseldorf, pp 475–485
Cramer RD III, Patterson DE, Bunce JD (1988) Comparative Molecular Field Analysis (CoMFA) Effect of Shape on Binding of Steroids to Carrier Proteins. J Am Chem Soc 110:5959–5967
Cramer RD III, Patterson DE, Bunce JD (1989) Recent advances in comparative molecular field analysis (CoMFA). Prog Clin Biol Res 291:161–165
Creese I, Iversen SD (1973) Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res 55:369–382
De Cerqueira LP, Golbraikh A, Oloff S, Xiao Y, Tropsha A (2006) Combinatorial QSAR modeling of P-glycoprotein substrates. J Chem Inf Model 46:1245–1254
Downs GM, Willett P (1996) Similarity searching in databases of chemical structures. In: Lipkowitz KB, Boyd D (eds) Reviews in computational chemistry. VCH Publishers, New York, pp 1–65
EduSoft L (2003) MolconnZ version 4.05. http://www.eslc.vabiotech.com/ [4.05]
Fan Y, Shi LM, Kohn KW, Pommier Y, Weinstein JN (2001) Quantitative structure-antitumor activity relationships of camptothecin analogues: cluster analysis and genetic algorithm-based studies. J Med Chem 44:3254–3263
Flower DR (1999) Modelling G-protein-coupled receptors for drug design. Biochim Biophys Acta 1422:207–234
Girones X, Gallegos A, Carbo-Dorca R (2000) Modeling antimalarial activity: application of kinetic energy density quantum similarity measures as descriptors in QSAR. J Chem Inf Comput Sci 40:1400–1407
Golbraikh A, Tropsha A (2002a) Beware of q 2! J Mol Graph Model 20:269–276
Golbraikh A, Tropsha A (2002b) Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. J Comput Aided Mol Des 16:357–369
Golbraikh A, Shen M, Xiao Z, Xiao YD, Lee KH, Tropsha A (2003) Rational selection of training and test sets for the development of validated QSAR models. J Comput Aided Mol Des 17:241–253
Gussio R, Pattabiraman N, Kellogg GE, Zaharevitz DW (1998) Use of 3D QSAR methodology for data mining the National Cancer Institute Repository of Small Molecules: application to HIV-1 reverse transcriptase inhibition. Methods 14:255–263
Hibert MF, Trumpp-Kallmeyer S, Bruinvels A, Hoflack J (1991) Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. Mol Pharmacol 40:8–15
Horn F, Weare J, Beukers MW, Horsch S, Bairoch A, Chen W, Edvardsen O, Campagne F, Vriend G (1998) GPCRDB: an information system for G protein-coupled receptors. Nucleic Acids Res 26:275–279
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–96
Kovatcheva A, Golbraikh A, Oloff S, Xiao YD, Zheng W, Wolschann P, Buchbauer G, Tropsha A (2004) Combinatorial QSAR of ambergris fragrance compounds. J Chem Inf Comput Sci 44:582–595
Kozikowski AP, Roth B, Tropsha A (2006) Why academic drug discovery makes sense. Science 313:1235–1236
Kubinyi H, Hamprecht FA, Mietzner T (1998) Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices. J Med Chem 41:2553–2564
Maybridge (2005) http://www.daylight.com/products/databases/Maybridge html
Minor DL, Wyrick SD, Charifson PS, Watts VJ, Nichols DE, Mailman RB (1994) Synthesis and molecular modeling of 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonists. J Med Chem 37:4317–4328
Moron JA, Campillo M, Perez V, Unzeta M, Pardo L (2000) Molecular determinants of MAO selectivity in a series of indolylmethylamine derivatives: biological activities, 3D-QSAR/CoMFA analysis, and computational simulation of ligand recognition. J Med Chem 43:1684–1691
National Cancer Institute (2004) Smiles strings. http://dtp.nci.nih.gov/docs/3d_database/structural_information/smiles_strings.html. Cited 28 November 2006
National Cancer Institute (2005) http://dtp.nci.nih.gov/docs/3d_database/structural_information/smiles_strings html
Norinder U (1996) Single and domain made variable selection in 3D QSAR applications. J Chemomet 10:95–105
Novellino E, Fattorusso C, Greco G (1995) Use of comparative molecular field analysis and cluster analysis in series design. Pharm Acta Helv 70:149–154
Okuno Y, Yang J, Taneishi K, Yabuuchi H, Tsujimoto G (2006) GLIDA: GPCR-ligand database for chemical genomic drug discovery. Nucleic Acids Res 34:D673–D677
Oloff S, Mailman RB, Tropsha A (2005) Application of validated QSAR models of D1 dopaminergic antagonists for database mining. J Med Chem 48:7322–7332
Oprea TI (2001) Rapid estimation of hydrophobicity for virtual combinatorial library analysis. SAR QSAR Environ Res 12:129–141
Oprea TI, Garcia A E (1996) Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors. J Comput Aided Mol Des 110:186–200
Phillips AG, Fibiger HC (1973) Dopaminergic and noradrenergic substrates of positive reinforcement: differential effects of d- and l-amphetamine. Science 179:575–577
Pijnenburg AJ, Honig WM, Van der Heyden JA, Van Rossum JM (1976) Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur J Pharmacol 35:45–58
Recanatini M, Cavalli A, Belluti F, Piazzi L, Rampa A, Bisi A, Gobbi S, Valenti P, Andrisano V, Bartolini M, Cavrini V (2000) SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues. J Med Chem 43:2007–2018
Roth BL, Kroeze WK (2006) Screening the receptorome yields validated molecular targets for drug discovery. Curr Pharm Des 12:1785–1795
Schulz DW, Wyrick SD, Mailman RB (1984) [3H]SCH23390 has the characteristics of a dopamine receptor ligand in the rat central nervous system. Eur J Pharmacol 106:211–212
Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED, Riederer P, Jellinger K, Tourtellotte WW (1987) Human brain D 1 and D 2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. Neuropsychopharmacology 1:5–15
Shay JW, Wright WE (2006) Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov 5:577–584
Shen M, LeTiran A, Xiao Y, Golbraikh A, Kohn H, Tropsha A (2002) Quantitative structure-activity relationship analysis of functionalized amino acid anticonvulsant agents using k nearest neighbor and simulated annealing PLS methods. J Med Chem 45:2811–2823
Shen M, Beguin C, Golbraikh A, Stables J, Kohn H, Tropsha A (2004) Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compounds. J Med Chem 47:2356–2364
Strange PG (1993) Brain biochemistry and brain disorders. Oxford University Press, New York
Sutherland JJ, Weaver DF (2004) Three-dimensional quantitative structure-activity and structure-selectivity relationships of dihydrofolate reductase inhibitors. J Comput Aided Mol Des 18:309–331
Suzuki T, Ide K, Ishida M, Shapiro S (2001) Classification of environmental estrogens by physicochemical properties using principal component analysis and hierarchical cluster analysis. J Chem Inf Comput Sci 41:718–726
Topliss JG, Edwards RP (1979) Chance factors in studies of quantitative structure-activity relationships. J Med Chem 22:1238–1244
Tropsha A, Zheng W (2001) Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining. Curr Pharm Des 7:599–612
Wold S, Eriksson L (1995) Statistical validation of QSAR results. In: Waterbeemd HVD (ed) Chemometrics methods in molecular design. VCH pp 309–318
Zefirov NS, Palyulin VA (2001) QSAR for boiling points of “small” sulfides. Are the “high-quality structure-property-activity regressions” the real high quality QSAR models? J Chem Inf Comput Sci 41:1022–1027
Zhang Y, Devries ME, Skolnick J (2006) Structure modeling of all identified G protein-coupled receptors in the human genome. PLoS Comput Biol 2:e13
Zheng W, Tropsha A (2000) Novel variable selection quantitative structure–property relationship approach based on the k-nearest-neighbor principle. J Chem Inf Comput Sci 40:185–194
Acknowledgements
This work was supported in part by the NIH research grant GM066940 and by Berlex Biosciences. We appreciate fruitful discussions with Drs. R. Horuk and Sabine Schlyer.
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
Copyright information
© 2007 Springer-Verlag
About this paper
Cite this paper
Tropsha, A., Wang, S.X. (2007). QSAR Modeling of GPCR Ligands: Methodologies and Examples of Applications. In: Bourne, H., Horuk, R., Kuhnke, J., Michel, H. (eds) GPCRs: From Deorphanization to Lead Structure Identification. Ernst Schering Foundation Symposium Proceedings, vol 2006/2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/2789_2006_003
Download citation
DOI: https://doi.org/10.1007/2789_2006_003
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-48981-8
Online ISBN: 978-3-540-48982-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)